What Do We Know So Far about Ofatumumab for Relapsing Multiple Sclerosis? A Meta-Analytical Study

por Taj, Hafiza Munazza, Talib, Maryam, Siddiqa, Sania, Sarfraz, Azza, Sarfraz, Zouina, Robles-Velasco, Karla, Cherrez-Ojeda, Ivan
Publicado 2022